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Proportions (95% confidence intervals) ofrespondents who had nebulisers in their practice and who took peakflow meters
on house calls and change in respondents' responses between 1989 and 1994
All respondents
Paired comparison
1989 1994 between 1989 and 1994
%0(95% % (95% Median change
Confidence Confidence No of (interquartile
No intervals) No intervals) pairs range)* Pt
Nebuliser in practice 198 91-4 (87-5 to 95 3) 189 98-4 (96-6 to 100-2) 146 0 (0 to 1) 0 03
Takes meteron house calls 198 31-8 (25-3 to 38-3) 191 34-6 (27-8 to 41-4) 148 0 (Oto2) 09
*Positive values indicate increase. tSigned rank statistic.
In Evans and colleagues' study 44% of the
practitioners either carried a nebuliser or said that
one was available in their surgery. The difference
in proportions of practices with a nebuliser is 54%
(95% confidence interval 45% to 62%) between
their study and ours. Similarly, 54% of the practi-
tioners in Evans and colleagues' study carried a
peak flow meter and the difference in proportions
is 19% (9% to 290/6). The differences in the
proportions are therefore significant, with more
practices having nebulisers yet fewer practi-
tioners usually taking meters on house calls in
Northern Ireland. Although this may reflect the
different methods and emphases of the two sur-
veys, it suggests that important inter-regional
differences in asthma care by general practitioners
may exist. This has important implications for
research into asthma care by general practitioners
because we cannot assume that care in one geo-
graphical region is representative; any attempt
to draw generalisable conclusions will require a
national sample.
RKMCKINLEY
Senior lecturer
Department of General Practice,
University of Leicester,
Leicester General Hospital,
Leicester LE5 4PW
WK STEELE
Senior lecturer
Departnent of General Practice,
Queen's University of Belfast,
Dunluce Health Centre,
Belfast BT9 7HR
1 Evans SA, Stoner J, Hardy C. Are general practitioners equipped
to manage acute severe asthma? BMJ 1994;309:1486. (3
December.)
2 McKinley RK, Jamison JP. The use of and attitude to peak flow
measurement in general practice. IrMedy 1994;87:84-5.
The study in 1989 was conducted while RK McKinley
held a research fellowship from the Department of
Health and Social Security (Northern Ireland) in the
department ofgeneral practice at the Queen's Univer-
sity of Belfast, and the study in 1994 was financed by a
grant from the National Asthma Campaign.
Chickenpox in the tropics
EDITOR,-In their editorial on immunisation
against chickenpox Lainie Friedman Ross and
John D Lantos fail to recognise that chickenpox is
more severe in the tropics than in temperate
climes.' The reason for this lies in the differences in
the age specific incidence of chickenpox between
the regions.
In Singapore the peak incidence of chickenpox
occurs in adolescence and young adulthood2 and is
associated with low herd immunity to chickenpox
in the young adult population.3 In recent times this
trend has also been observed in populations living
in temperate regions.4 5 Although chickenpox is
benign in childhood, in adults it is associated with
more severe disease. In pregnant women it is also
associated with the risk of chickenpox in the
unborn fetus and newborn infant. The social costs
of the disease would also be expected to be higher
than those estimated for populations in which
chickenpox occurs mainly in childhood. It is
therefore erroneous to assume that chickenpox is
benign in all populations.
Since vaccination against chickenpox is most
efficacious in childhood, a universal immunisation
programme should be targeted at young children.
The epidemiology of chickenpox and its age
specific incidence should be taken into considera-
tion when the issue of mass chickenpox in a
particular population is addressed. In this regard,
universal immunisation of populations living in the
tropics may be justified.
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Differences in progression of
HIV infection between men and
women
EDrroR,-Alessandro Cozzi Lepri and colleagues
report little difference in progression of HIV
infection between men and women in the Italian
seroconversion study.' We have examined this
issue in the Swiss HIV cohort study, one of the
largest continuing studies of a seroprevalent cohort
(a cohort ofpeople with HIV infection in whom the
date ofseroconversion is not known). The study has
enrolled over 6000 participants from all transmis-
sion groups, including nearly 2000 women.2 In the
Swiss survey there was no evidence for differences
between the sexes in either progression to different
degrees ofCD4 lymphocytopenia or progression to
death when differences in DC4 cell counts at entry
were taken into account in the analysis.3
The authors emphasise the importance of
incident cohorts (cohorts in which the date of
seroconversion is known) for analysis of differ-
ences in the progression of HIV infection. The
similar results that we obtained from a sero-
prevalent cohort indicate, however, that time since
infection may have no independent prognostic
importance when CD4 cell counts are considered
in the analysis. Indeed, this conclusion was
reached in analyses of several incident cohorts,
including the Italian seroconversion study.45
Therefore, while incident cohorts are indispens-
able for answering several important questions,
seroprevalent cohorts may offer advantages in
other situations. One advantage is the generally
larger sample size, and therefore greater statistical
power; this is needed to detect or exclude smaller
differences in the progression of disease. For
example, the study by Cozzi Lepri and colleagues,
based on 854 patients and 42 deaths, could not
exclude the possibility of a 79% increase in
mortality from AIDS among women compared
with men. Conversely, an analysis of the Swiss
HIV cohort study based on 2871 patients and 761
deaths showed that such substantial differences
can be excluded with confidence.3
The only difference between the sexes found by
Cozzi Lepri and colleagues related to AIDS
defining cytomegalovirus infection. The authors
conclude, on the basis of four cases among women
and none among men (P = 0 01), that this infection
may be a more common AIDS defining event
among women. We have examined this suppo-
sition in the Swiss study by analysing the incidence
of disseminated cytomegalovirus infection in
participants who were infected either by injecting
drugs or heterosexually and who were free ofAIDS
at registration. Both univariate and multivriate
analyses indicate that there is no significant
difference between women and men in the occur-
rence of disseminated cytomegalovirus infection
over a mean follow up of three years-if anything,
there was a trend in the opposite direction (table).
This analysis thus fails to confirm the results of
Cozzi Lepri and colleagues. Because of the large
number of AIDS-defining conditions tested, their
finding may be a false positive result due to a type 1
error. Indeed, applying a Bonferroni-type correc-
tion renders their P value non-significant.
In conclusion, the examples presented here
show how analyses of incident and seroprevalent
cohorts can sensibly complement each other.
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Heart muscle disease related to
HIV infecdon
ED1TOR,-We agree with Peter F Currie and
colleagues that the aetiology of heart muscle
disease in HIV infection is unknown.' Given that
most HIV infection occurs in the developing
world, conditions such as rheumatic heart disease
may contribute to cardiac complications in HIV
infection even though a significant interaction has
not yet been noted.2 We report a case of rheumatic
heart disease characterised by atypical clinical and
laboratory features in a man positive for HIV.
A 28 year old African immigrant presented with
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